부산대학교 도서관

Ortega Polledo LE; Instituto de Urología de la Peña-Hidalgo-Alonso, Madrid, Spain; Hospital Clínico San Carlos, Servicio de Urología, Madrid, Spain. Electronic address: luisenor@ucm.es.; Sánchez Pellejero A; Instituto de Urología de la Peña-Hidalgo-Alonso, Madrid, Spain; Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.; Bianchini Hernández GFJ; Instituto de Urología de la Peña-Hidalgo-Alonso, Madrid, Spain; Hospital Central de la Defensa Gómez Ulla, Madrid, Spain.; García Rico E; Instituto de Urología de la Peña-Hidalgo-Alonso, Madrid, Spain; Hospital Clínico San Carlos, Servicio de Urología, Madrid, Spain.; Redondo González E; Hospital Clínico San Carlos, Servicio de Urología, Madrid, Spain; Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid, Spain; Universidad Complutense de Madrid, Spain.; Subiela Henríquez JD; Hospital Universitario Ramón y Cajal, Servicio de Urología, Madrid, Spain.; Mata Deniz P; Hospital Clínico San Carlos, Servicio de Urología, Madrid, Spain.; Marugán Álvarez MJ; Hospital Clínico San Carlos, Servicio de Urología, Madrid, Spain.; Gómez Rivas J; Hospital Clínico San Carlos, Servicio de Urología, Madrid, Spain; Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid, Spain; Universidad Complutense de Madrid, Spain.; Galante Romo I; Hospital Clínico San Carlos, Servicio de Urología, Madrid, Spain; Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid, Spain.; Moreno Sierra J; Hospital Clínico San Carlos, Servicio de Urología, Madrid, Spain; Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid, Spain; Universidad Complutense de Madrid, Spain.; Ahyai S; Medical University of Graz, Department of Urology, Graz, Austria.; Miñana B; Clínica Universidad de Navarra, Servicio de Urología, Madrid, Spain.; Alonso Y Gregorio S; Instituto de Urología de la Peña-Hidalgo-Alonso, Madrid, Spain.

Publisher: Elsevier España Country of Publication: Spain NLM ID: 101771154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5786 (Electronic) Linking ISSN: 21735786 NLM ISO Abbreviation: Actas Urol Esp (Engl Ed) Subsets: MEDLINE

Artiles Medina A; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, University of Alcalá, Madrid, Spain - alberc.artiles@gmail.com.; Subiela Henríquez JD; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, University of Alcalá, Madrid, Spain.; Muriel García A; Unit of Clinical Biostatistics, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBERESP, University of Alcalá, Madrid, Spain.; Mínguez Ojeda C; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, University of Alcalá, Madrid, Spain.; Sánchez González Á; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, University of Alcalá, Madrid, Spain.; DE LA Parra Sánchez I; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, University of Alcalá, Madrid, Spain.; López Curtis D; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, University of Alcalá, Madrid, Spain.; Gómez Dos Santos V; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, University of Alcalá, Madrid, Spain.; Jiménez Cidre MÁ; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, University of Alcalá, Madrid, Spain.; Burgos Revilla FJ; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, University of Alcalá, Madrid, Spain.

Publisher: Edizioni Minerva Medica Country of Publication: Italy NLM ID: 101777299 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2724-6442 (Electronic) Linking ISSN: 27246051 NLM ISO Abbreviation: Minerva Urol Nephrol Subsets: MEDLINE; In Process

Fernández-Conejo G; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain. gfernandezc90@gmail.com.; Subiela Henríquez JD; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.; Tagalos Muñoz A; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.; González Álvarez C; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.; Fernández Mardomingo A; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.; Sanz Mayayo E; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.; Díez Nicolás V; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.; García Barreras S; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.; Gómez Dos Santos V; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.; Rodríguez-Patrón R; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.; Burgos Revilla FJ; Hospital Ramón y Cajal, M-607, Km. 9, 100, Madrid, Spain.

Publisher: Springer Country of Publication: England NLM ID: 101300401 Publication Model: Electronic Cited Medium: Internet ISSN: 1863-2491 (Electronic) Linking ISSN: 18632483 NLM ISO Abbreviation: J Robot Surg Subsets: MEDLINE

Contieri R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.; Martini A; Department of Urology, University of Cincinnati, Cincinnati, OH, USA.; Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Compérat EM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Čapoun O; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Maxim Bruins H; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.; Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Seles M; Department of Urology, Medical University of Graz, Graz, Austria.; Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Kusuma VRM; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Ashabere D; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Seisen T; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Masson-Lecomte A; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France.; Liedberg F; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Skaanes Universitetssjukhus, Malmö, Sweden.; Cohen D; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free London NHS Foundation Trust, London, UK.; Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Sheikh SE; Department of Pathology, Royal Free London NHS Foundation Trust, London, UK.; Volanis D; Department of Urology, Royal Free London NHS Foundation Trust, London, UK.; Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP and Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.; Rouprêt M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Shariat SF; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Zigeuner R; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.; Dominguez-Escrig JL; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.; Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Evert M; Department of Pathology, University of Regensburg, Regensburg, Germany.; de Kaa CAH; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Kiemeney LALM; IQ Health and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Soukup V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Hurle R; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.; Paciotti M; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.; Moschini M; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; Pradere B; Department of Urology UROSUD, La Croix du Sud Hôpital, Quint Fonsegrives, France.; Perdonà S; Uro-Gynecological Department, Istituto Nazionale Tumori di Napoli G. Pascale IRCCS, Naples, Italy.; Gontero P; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Palou J; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Ribal MJ; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Mínguez Ojeda C; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Artiles Medina A; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain. Electronic address: alberc.artiles@gmail.com.; Fraile Poblador A; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Sánchez González Á; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Subiela Henríquez JD; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Brasero Burgos J; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; de la Parra Sánchez I; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; López Curtis D; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Del Olmo Durán P; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Fernández-Mardomingo Díaz A; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Jiménez Cidre MA; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Gómez Dos Santos V; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Burgos Revilla FJ; Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Publisher: Elsevier España Country of Publication: Spain NLM ID: 101771154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5786 (Electronic) Linking ISSN: 21735786 NLM ISO Abbreviation: Actas Urol Esp (Engl Ed) Subsets: MEDLINE

Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Bründl J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Compérat EM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Plass K; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; Rodríguez O; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Subiela Henríquez JD; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; de la Peña E; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Alemany I; Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Pisano F; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Soria F; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Čapoun O; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Bauerová L; Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Pešl M; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Bruins HM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Urology, Zuyderland Medical Center, Sittard/Heerlen, The Netherlands.; Runneboom W; Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Breyer J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Brisuda A; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Calatrava A; Pathology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.; Rubio-Briones J; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.; Seles M; Urology, Medical University of Graz, Graz, Austria.; Mannweiler S; Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Kusuma VRM; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Ashabere D; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Cotte J; Urology, Pitié Salpétrière Hospital, AP-HP, GRC no 5, ONCOTYPE-URO, Sorbonne University, 75013, Paris, France.; Contieri R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Masson-Lecomte A; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Liedberg F; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Cohen D; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK.; Lunelli L; Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Cussenot O; Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; El Sheikh S; Pathology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK.; Volanis D; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK.; Côté JF; Pathology, Pierre et Marie Curie Medical School, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Rouprêt M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Pitié Salpétrière Hospital, AP-HP, GRC no 5, ONCOTYPE-URO, Sorbonne University, 75013, Paris, France.; Haitel A; Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Shariat SF; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Nieuwenhuijzen JA; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Zigeuner R; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Medical University of Graz, Graz, Austria.; Dominguez-Escrig JL; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.; Hacek J; Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Zlotta AR; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Burger M; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Evert M; Pathology, University of Regensburg, Regensburg, Germany.; Hulsbergen-van de Kaa CA; Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; van der Heijden AG; Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Kiemeney LALM; Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Soukup V; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Molinaro L; Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Gontero P; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Llorente C; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Algaba F; Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Palou J; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; N'Dow J; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; Ribal MJ; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. b.v.rhijn@nki.nl.; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany. b.v.rhijn@nki.nl.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. b.v.rhijn@nki.nl.; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. b.v.rhijn@nki.nl.

Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2584 (Electronic) Linking ISSN: 03011623 NLM ISO Abbreviation: Int Urol Nephrol Subsets: MEDLINE

Ortega Polledo LE; Department of Urology, Prince of Asturias University Hospital, University of Alcalá, Madrid, Spain - leortegapolledo@gmail.com.; Institute of Urology, Hospital Universitario San Francisco de Asís, Alfonso X El Sabio University, Madrid, Spain - leortegapolledo@gmail.com.; European Society of Residents in Urology (ESRU), Arnhem, the Netherlands - leortegapolledo@gmail.com.; Mantica G; European Society of Residents in Urology (ESRU), Arnhem, the Netherlands.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.; Carrión DM; European Society of Residents in Urology (ESRU), Arnhem, the Netherlands.; Department of Urology, Torrejón University Hospital, Francisco de Vitoria University, Madrid, Spain.; Khelif A; European Society of Residents in Urology (ESRU), Arnhem, the Netherlands.; Centre Hospitalier Inter Régional Edith Cavel (CHIREC), Braine-l'Alleud, Belgium.; Subiela Henríquez JD; European Society of Residents in Urology (ESRU), Arnhem, the Netherlands.; Department of Urology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, University of Alcalá, Madrid, Spain.; González Padilla DA; European Society of Residents in Urology (ESRU), Arnhem, the Netherlands.; Department of Urology, Clínica Universidad de Navarra (CUN), Madrid, Spain.; Sanchís Bonet Á; Department of Urology, Prince of Asturias University Hospital, University of Alcalá, Madrid, Spain.; Tamayo Ruiz JC; Department of Urology, Prince of Asturias University Hospital, University of Alcalá, Madrid, Spain.; García Rico E; Institute of Urology, Hospital Universitario San Francisco de Asís, Alfonso X El Sabio University, Madrid, Spain.; Department of Urology, Torrejón University Hospital, Francisco de Vitoria University, Madrid, Spain.; Alonso Gregorio S; Institute of Urology, Hospital Universitario San Francisco de Asís, Alfonso X El Sabio University, Madrid, Spain.; Gómez Rivas J; European Society of Residents in Urology (ESRU), Arnhem, the Netherlands.; Department of Urology, Hospital Clinico San Carlos, Madrid, Spain.; Esperto F; European Society of Residents in Urology (ESRU), Arnhem, the Netherlands.; Department of Urology, Campus Bio-Medico University, Rome, Italy.; Scoffone CM; Department of Urology, Cottolengo Hospital, Turin, Italy.; Cracco CM; Department of Urology, Cottolengo Hospital, Turin, Italy.; Checcucci E; European Society of Residents in Urology (ESRU), Arnhem, the Netherlands.; Department of Surgery, FPO-IRCCS Candiolo Cancer Institute, Candiolo, Turin, Italy.

Publisher: Edizioni Minerva Medica Country of Publication: Italy NLM ID: 101777299 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2724-6442 (Electronic) Linking ISSN: 27246051 NLM ISO Abbreviation: Minerva Urol Nephrol Subsets: MEDLINE; PubMed not MEDLINE

Artiles Medina A; Department of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain.; Mínguez Ojeda C; Department of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain. Electronic address: cesar.minguez.1994@gmail.com.; Subiela Henríquez JD; Department of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain.; Muriel García A; Clinical Biostatistics Unit, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBERESP, University of Alcalá, Madrid, Spain.; Sánchez González Á; Department of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain.; Mata Alcaraz M; Department of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain.; Brasero Burgos J; Department of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain.; Gajate Borau P; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Gómez Dos Santos V; Department of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain.; Jiménez Cidre MÁ; Department of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain.; Burgos Revilla FJ; Department of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Sylvester RJ; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. Electronic address: richard.sylvester@skynet.be.; Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Max Bruins H; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Seles M; Department of Urology, Medical University of Graz, Graz, Austria.; Hentschel AE; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Volanis D; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Cussenot O; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.; Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.; El Sheikh S; Department of Pathology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.; Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Evert M; Department of Pathology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Kiemeney LALM; Department of Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.; N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Čapoun O; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Soukup V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Dominguez-Escrig JL; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Cohen D; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Palou J; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Gontero P; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Burger M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Zigeuner R; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.; Mostafid AH; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Shariat SF; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Rouprêt M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Compérat EM; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Babjuk M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; van Rhijn BWG; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE; PubMed not MEDLINE

Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Compérat EM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Čapoun O; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Bruins HM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.; Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Seles M; Department of Urology, Medical University of Graz, Graz, Austria.; Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Masson-Lecomte A; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Liedberg F; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Cohen D; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.; Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; El Sheikh S; Department of Pathology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.; Volanis D; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.; Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.; Rouprêt M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.; Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Shariat SF; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Zigeuner R; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.; Dominguez-Escrig JL; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.; Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Evert M; Department of Pathology, University of Regensburg, Regensburg, Germany.; Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Kiemeney LALM; Department of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Soukup V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Gontero P; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Algaba F; Deaprtment of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Palou J; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Ribal MJ; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Compérat EM; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Plass K; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Čapoun O; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Maxim Bruins H; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Seles M; Department of Urology, Medical University of Graz, Graz, Austria.; Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC no. 5, Oncotype-Uro, Sorbonne University, Paris, France.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Masson-Lecomte A; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Liedberg F; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Cohen D; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.; Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; El Sheikh S; Department of Pathology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.; Volanis D; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.; Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.; Rouprêt M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC no. 5, Oncotype-Uro, Sorbonne University, Paris, France.; Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Shariat SF; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Zigeuner R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.; Dominguez-Escrig JL; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Evert M; Department of Pathology, University of Regensburg, Regensburg, Germany.; Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; A L M Kiemeney L; Department of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Soukup V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Gontero P; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Palou J; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; N'Dow J; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; Ribal MJ; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE

Sylvester RJ; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. Electronic address: richard.sylvester@skynet.be.; Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Bruins HM; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Seles M; Department of Urology, Medical University of Graz, Graz, Austria.; Hentschel AE; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Volanis D; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Cussenot O; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.; Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.; El Sheikh S; Department of Pathology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.; Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Evert M; Department of Pathology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Kiemeney LALM; Department of Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.; N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Čapoun O; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Soukup V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Dominguez-Escrig JL; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Cohen D; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Palou J; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Gontero P; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Burger M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Zigeuner R; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.; Mostafid AH; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Shariat SF; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Rouprêt M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Compérat EM; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Babjuk M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; van Rhijn BWG; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Campi R; Department of Urology, University of Florence, Careggi Hospital, Florence, Italy. Electronic address: riccardo.campi@unifi.it.; Brookman-May SD; Department of Urology, Ludwig-Maximilians University (LMU) Munich, Munich, Germany. Electronic address: sabine.brookman-may@email.de.; Subiela Henríquez JD; Uro-oncology Unit, Fundacio Puigvert, Barcelona, Spain. Electronic address: jdsubiela@fundacio-puigvert.es.; Akdoğan B; Department of Urology, Hacettepe University, School of Medicine, Ankara, Turkey. Electronic address: blntakdogan@yahoo.com.; Brausi M; Department of Urology, B. Ramazzini Hospital, Carpi-Modena, Italy. Electronic address: m.brausi@ausl.mo.it.; Klatte T; Department of Urology, Addenbrooke's Hospital, Cambridge, UK. Electronic address: tobias.klatte@addenbrookes.nhs.uk.; Langenhuijsen JF; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Hans.Langenhuijsen@radboudumc.nl.; Linares-Espinos E; University Hospital La Paz, Madrid, Spain. Electronic address: estefanialinares@gmail.com.; Marszalek M; Department of Urology and Andrology, Donauspital, Vienna, Austria. Electronic address: martin.marszalek@wienkav.at.; Roupret M; Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Department of Urology, Pitié-Salpétrière Hospital, F-75013, Paris, France. Electronic address: morgan.roupret@psl.aphp.fr.; Stief CG; Department of Urology, Ludwig-Maximilians University (LMU) Munich, Munich, Germany. Electronic address: christian.stief@med.uni-muenchen.de.; Volpe A; Department of Urology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy. Electronic address: alessandro.volpe@med.uniupo.it.; Minervini A; Department of Urology, University of Florence, Careggi Hospital, Florence, Italy. Electronic address: andrea.minervini@unifi.it.; Rodriguez-Faba O; Uro-oncology Unit, Fundacio Puigvert, Barcelona, Spain. Electronic address: orodriguez@fundacio-puigvert.es.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE

van Rhijn BWG; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: basvanrhijn@hotmail.com.; Hentschel AE; Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Bründl J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Compérat EM; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Hernández V; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Čapoun O; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Bruins HM; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Cohen D; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Royal Free London - NHS Foundation Trust, Royal Free Hospital, London, UK.; Rouprêt M; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.; Shariat SF; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Zigeuner R; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Medical University of Graz, Graz, Austria.; Dominguez-Escrig JL; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.; Burger M; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Soukup V; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Gontero P; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Palou J; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE